Squarepoint’s Savara SVRA Stock Holding History

Squarepoint’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Sell	33,288 -137,531	-81%	-$738K	﹤0.01%	4052
2026 Q1	$933K	Buy	+170,819	New	+$951K	﹤0.01%	2826
2025 Q4	–	Sell	-25,136	Closed	-$89.7K	–	4874
2025 Q3	$89.7K	Buy	+25,136	New	+$74.3K	﹤0.01%	4133
2025 Q2	–	Sell	-75,350	Closed	-$209K	–	5033
2025 Q1	$209K	Sell	75,350 -47,285	-39%	-$131K	﹤0.01%	3990
2024 Q4	$376K	Buy	122,635 +78,540	+178%	+$274K	﹤0.01%	3982
2024 Q3	$187K	Sell	44,095 -68,143	-61%	-$301K	﹤0.01%	3709
2024 Q2	$452K	Buy	+112,238	New	+$499K	﹤0.01%	3149
2023 Q2	–	Sell	-16,206	Closed	-$31.6K	–	4000
2023 Q1	$31.6K	Buy	+16,206	New	+$36.5K	﹤0.01%	3094
2021 Q2	–	Sell	-43,487	Closed	-$90K	–	3677
2021 Q1	$90K	Buy	+43,487	New	+$74.4K	﹤0.01%	2923
2020 Q4	–	Sell	-19,555	Closed	-$21K	–	3251
2020 Q3	$21K	Sell	19,555 -53,215	-73%	-$91K	﹤0.01%	2417
2020 Q2	$181K	Buy	+72,770	New	+$177K	﹤0.01%	1848
2020 Q1	–	Sell	-44,202	Closed	-$198K	–	2484
2019 Q4	$198K	Buy	+44,202	New	+$53.2K	﹤0.01%	2231
2019 Q2	–	Sell	-15,506	Closed	-$114K	–	2656
2019 Q1	$114K	Buy	+15,506	New	+$117K	﹤0.01%	2023

Other funds holding SVRA

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Squarepoint's SVRA Position: Q2 2026 in Review

Squarepoint reduced its Savara (SVRA) stake by 81% in Q2 2026, selling an estimated $738K and leaving 33,288 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #4052.

Squarepoint first reported a position in SVRA in Q1 2019 and has held it in 13 quarters since. The position peaked at $933K in Q1 2026. 180 funds tracked by Wall St. Rank hold SVRA as of Q2 2026.

Squarepoint held 33,288 shares of Savara worth $205K as of Q2 2026.
Squarepoint sold 137,531 Savara shares in Q2 2026, an estimated $738K.
Savara made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4052 holding.
Squarepoint first reported a position in Savara in Q1 2019 and has held it in 13 quarters since.
Squarepoint's Savara position peaked at $933K in Q1 2026.
180 funds tracked by Wall St. Rank held Savara as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.